Genes Chromosomes and Cancer · 2007 · 66 citations · 25 references
MedicineGeneticsOncologyEpigeneticsGene ExpressionTranscriptional RegulationCancer EpigeneticsCancer EpigenomicsDna MethylationDna Methylation ProfilingEpigenetic BiomarkersEpigenetic Regulation In CancerAberrant Dna MethylationAcute Myeloid Leukemia BiologyCancer Epigenetic BiomarkersMinimal Residual Disease MarkersOncogene Hypomethylation
The preferentially expressed antigen of melanoma (PRAME) is expressed at high levels in large fractions of human malignancies, e.g., acute myeloid leukemia. Therefore, PRAME is an important marker for diagnosis of various malignant diseases and a relevant parameter for monitoring minimal residual disease. It is supposed to be involved in tumorigenic processes. Because of these important aspects we investigated its transcriptional regulation in detail. Most relevant was a detailed DNA methylation analysis of the PRAME 5' region by genomic sequencing in correlation with PRAME expression in various human patient samples and cell lines. In combination with DNA-truncation/transfection experiments with respect to DNA methylation, we show that changes in the methylation pattern in defined parts of the regulatory regions of PRAME are sufficient for its upregulation in cells usually not expressing the gene.
25
Gene expression profiling predicts clinical outcome of breast cancer
Laura van ‘t Veer, Hongyue Dai, Marc J. van de Vijver et al. · Nature · 2002 · 9.6K citations · Full text